Kosin Medical Journal (고신대학교 의과대학 학술지)

Kosin University College of Medicine (고신대학교 의과대학)
권호 표지
DOI QR코드

DOI QR Code

Empirical antibiotics for recurrent urinary tract infections in children

  • Choi, Hyun Gil (Department of Pediatrics, College of Medicine, Kosin University) ;
  • Lee, Ji Young (Department of Pediatrics, College of Medicine, Kosin University) ;
  • Oh, Chi Eun (Department of Pediatrics, College of Medicine, Kosin University)
  • Received : 2016.09.09
  • Accepted : 2016.10.19
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study was to compare antibiotic resistance patterns between first urinary tract infection (UTI) and recurrent UTI groups and to obtain information regarding empirical antibiotic selection for treating recurrent UTI. Methods: We retrospectively reviewed 148 children treated for UTIs from January 2009 to June 2016. The patients were divided into two groups: first UTI (N = 148) and recurrent UTI (17 patients and 20 episodes). Results: In both groups, Escherichia coli was the most frequent causative organism, accounting for 89.9% and 75.0% in the first and recurrent UTI groups, respectively. When E. coli or Klebsiella pneumoniae was the causative organism, extended-spectrum ${\beta}-lactamase$ (ESBL)-producing organisms were more frequent in the recurrent UTI group (17.6%) than in the first UTI group (14.0%); however, this difference was not statistically significant (P = 0.684). Cefotaxime was the most frequently used first-line empirical antibiotic in both groups. In the first UTI and recurrent UTI groups, 7.4% and 15.0% of patients were treated with intravenous antibiotics as definitive therapy, respectively (P = 0.250). Fifteen out of 17 patients having a second UTI had different causative organisms or antibiotic susceptibility patterns compared to their previous episode. Conclusions: Escherichia coli was the most frequent causative organism in the recurrent UTI group. There were no differences in the proportion of ESBL-producing organisms between the first UTI and recurrent UTI groups. Therefore, when a UTI recurs in children, the antibiotics effective on the most common causative organism might be administered as empirical antibiotics.

Keywords

References

  1. Elder JS. Urinary tract infections. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier Health Sciences; 2015. p.2556-62.
  2. Roberts KB, Akintemi OB. The epidemiology and clinical presentation of urinary tract infections in children younger than 2 years of age. Pediatr Ann 1999;28:644-9. https://doi.org/10.3928/0090-4481-19991001-08
  3. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013;190:222-7. https://doi.org/10.1016/j.juro.2013.01.069
  4. Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol 2001;16:69-72. https://doi.org/10.1007/s004670000493
  5. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113:5S-13S.
  6. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011;128:595-610. https://doi.org/10.1542/peds.2011-1330
  7. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Urinary Tract Infection. Pediatrics 1999;103:843-52. https://doi.org/10.1542/peds.103.4.843
  8. Temiz Y, Tarcan T, Onol FF, Alpay H, Simsek F. The Efficacy of Tc99m dimercaptosuccinic acid (Tc-DMSA) scintigraphy and ultrasonography in detecting renal scars in children with primary vesicoureteral reflux (VUR). Int Urol Nephrol 2006;38:149-52. https://doi.org/10.1007/s11255-005-3829-6
  9. Dudley JA, Haworth JM, McGraw ME, Frank JD, Tizard EJ. Clinical relevance and implications of antenatal hydronephrosis. Arch Dis Child Fetal Neonatal Ed 1997;76:F31-4. https://doi.org/10.1136/fn.76.1.F31
  10. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: Introduction to the system used by the society for fetal urology. Pediatr Radiol 1993;23:478-80. https://doi.org/10.1007/BF02012459
  11. Lidefelt KJ, Ek S, Mihocsa L. Is screening for vesicoureteral reflux mandatory in infants with antenatal renal pelvis dilatation? Acta Paediatr 2006;95:1653-6. https://doi.org/10.1080/08035250600764826
  12. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Mobius TE. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985;15:105-9. https://doi.org/10.1007/BF02388714
  13. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179-86. https://doi.org/10.1001/jama.298.2.179
  14. Kang YD, Kim NS, Oh SH. Causative organisms of urinary tract infection in children, and their antibiotic susceptibility. Korean J Pediatr 2004;47:1065-71.
  15. Lee YK, Lee HJ, Kim JM, Kang JM, Lee ST, Lee NY, et al. The antibiotic resistance pattern of gram-negative bacteria in children younger than 24 months with a urinary tract infection : a retrospective single-center study over 15 consecutive years. Child Kidney Dis 2015;19:148-53. https://doi.org/10.3339/chikd.2015.19.2.148
  16. Li XM, Jang SJ, Bae IK, Park G, Kim YS, Shin JH, et al. [Frequency of extended-spectrum $\beta$ -lactamase (ESBL) and AmpC $\beta$-lactamase genes in Escherichia coli and Klebsiella pneumoniae over a three-year period in a university hospital in Korea]. Korean J Lab Med 2010;30:616-23. https://doi.org/10.3343/kjlm.2010.30.6.616
  17. Megged O. Extended-spectrum $\beta$-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol 2014;29:1583-7. https://doi.org/10.1007/s00467-014-2810-y
  18. Gavin PJ, Suseno MT, Thomson RB Jr, Gaydos JM, Pierson CL, Halstead DC, et al. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum-$\beta$ -lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother 2006;50:2244-7. https://doi.org/10.1128/AAC.00381-05
  19. Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended- spectrum $\beta$ -lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 2008;14:181-4. https://doi.org/10.1111/j.1469-0691.2007.01864.x
  20. Rodriguez-Bano J, Navarro MD, Retamar P, Picon E, Pascual A; Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group. $\beta$-Lactam/$\beta$-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum $\beta$-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 2012;54:167-74. https://doi.org/10.1093/cid/cir790
  21. Perez F, Bonomo RA. Can we really use $\beta$-lactam/$\beta$-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum $\beta$-lactamase-producing bacteria? Clin Infect Dis 2012;54:175-7. https://doi.org/10.1093/cid/cir793
  22. Park KH, Lee EH, Kim MK, Lee JH, Choi BM, Yoo KH, et al. Febrile urinary tract infection in infants less than two months of age : characteristics and factors related to the recurrence. J Korean Soc Neonatol 2012;19:91-7. https://doi.org/10.5385/jksn.2012.19.2.91